
zzso is an zzso zzso zzso with remarkable efficacy in zzso multiple sclerosis zzso In clinical trials and zzso use in zzso zzso has been administered zzso zzso zzso is approved for chronic zzso leukemia as zzso Oncology guidelines recommend zzso subcutaneous zzso over zzso There is no report of zzso SC in zzso We report two patients with highly active zzso zzso who were treated with SC zzso had significant improvement and tolerated SC zzso well without the typical zzso adverse zzso SC zzso in zzso warrants further studies as this may enhance patient convenience and minimize zzso adverse zzso 

